Datasets
Buyer room
EVIASEARCH.COMManage supplier listing
EviaSearch — Audited capability graph of the global pharma outsourcing market: structured, eligibility-audited profiles for CDMOs, CMOs/CRAMs, CROs, BA/BE service providers and toxicology labs, mapped by molecule and CAS number to the specific providers capable of manufacturing or testing each molecule, with verified capability parameters, credentials and site qualifications behind a side-by-side comparison scoring layer. Micro-scale marketplace (9 employees, research industry, Thane India, no disclosed funding) with an unusually complete asset for its size: an audited, molecule-keyed map of …
supplier index read from their site
Audited capability graph of the global pharma outsourcing market: structured, eligibility-audited profiles for CDMOs, CMOs/CRAMs, CROs, BA/BE service providers and toxicology labs, mapped by molecule and CAS number to the specific providers capable of manufacturing or testing each molecule, with verified capability parameters, credentials and site qualifications behind a side-by-side comparison scoring layer
From 5 yearsFormat TabularCoverage Health Care · Industrials
Sample, licence terms, pricing and eval results when EviaSearch publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →What buyers ask about EviaSearch, answered from this page.
EviaSearch — Audited capability graph of the global pharma outsourcing market: structured, eligibility-audited profiles for CDMOs, CMOs/CRAMs, CROs, BA/BE service providers and toxicology labs, mapped by molecule and CAS number to the specific providers capable of manufacturing or testing each molecule, with verified capability parameters, credentials and site qualifications behind a side-by-side comparison scoring layer. Micro-scale marketplace (9 employees, research industry, Thane India, no disclosed funding) with an unusually complete asset for its size: an audited, molecule-keyed map of …
EviaSearch offers (Supply Chain, Reference, Alternative) — One audited structured profile per eligible provider across seven service categories (BA/BE, clinical research, finished-dose CRAMs/CDMOs, finished-dose CMOs, API and intermediates, third-party providers, toxicology labs), each mapped to the molecules and CAS numbers it can handle — a molecule-by-provider capability matrix running to hundreds of thousands of capability edges.
Pharma outsourcing market-share and capacity mapping by molecule and therapeutic class; supply-chain concentration and single-source risk analysis for critical APIs and toxicology testing; due-diligence and counterparty screening for generic and biosimilar developers; sourcing-demand nowcasting from enquiry volumes by molecule; training entity-resolution models that map CAS numbers to capable manufacturing sites
The data is with 5 years of history.
Coverage spans Other, US; Drug Discovery, Development & Delivery, Research & Consulting Services; supply_chain, reference, alternative; equities.
EviaSearch has not added their own details yet. Not yet on file: